{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:19:31Z","timestamp":1791231571545,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.autrev.2016.09.010","type":"journal-article","created":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T23:16:48Z","timestamp":1473981408000},"page":"1120-1124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":293,"title":["Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry"],"prefix":"10.1016","volume":"15","author":[{"given":"Ignasi","family":"Rodr\u00edguez-Pint\u00f3","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Moitinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Santacreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doruk","family":"Erkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricard","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6399","key":"10.1016\/j.autrev.2016.09.010_bb0005","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/bmj.287.6399.1088","article-title":"Thrombosis, abortion, cerebral disease, and the lupus anticoagulant","volume":"287","author":"Hughes","year":"1983","journal-title":"Br Med J"},{"issue":"4","key":"10.1016\/j.autrev.2016.09.010_bb0010","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2016.09.010_bb0015","first-page":"508","article-title":"The catastrophic antiphospholipid syndrome","volume":"19","author":"Asherson","year":"1992","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2016.09.010_bb0020","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.autrev.2014.03.002","article-title":"14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome","volume":"13","author":"Cervera","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.autrev.2016.09.010_bb0025","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1177\/0961203312436866","article-title":"CAPS Registry","volume":"21","author":"Cervera","year":"2012","journal-title":"Lupus"},{"issue":"7","key":"10.1016\/j.autrev.2016.09.010_bb0030","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1191\/0961203303lu394oa","article-title":"Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines","volume":"12","author":"Asherson","year":"2003","journal-title":"Lupus"},{"issue":"3\u20134","key":"10.1016\/j.autrev.2016.09.010_bb0035","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jaut.2009.02.008","article-title":"Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the \u201cCAPS Registry\u201d","volume":"32","author":"Cervera","year":"2009","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.autrev.2016.09.010_bb0040","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00005792-199805000-00005","article-title":"Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients","volume":"77","author":"Asherson","year":"1998","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.autrev.2016.09.010_bb0045","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00005792-200111000-00002","article-title":"Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients","volume":"80","author":"Asherson","year":"2001","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"10.1016\/j.autrev.2016.09.010_bb0050","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.autrev.2015.07.009","article-title":"The role of infectious diseases in the catastrophic antiphospholipid syndrome","volume":"14","author":"Garcia-Carrasco","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2016.09.010_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2008.10.003","article-title":"The physiopathology of the catastrophic antiphospholipid (Asherson's) syndrome: compelling evidence","volume":"32","author":"Ortega-Hernandez","year":"2009","journal-title":"J Autoimmun"},{"issue":"5","key":"10.1016\/j.autrev.2016.09.010_bb0060","first-page":"923","article-title":"Catastrophic antiphospholipid syndrome and sepsis. A common link?","volume":"34","author":"Espinosa","year":"2007","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2016.09.010_bb0065","first-page":"12","article-title":"The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome-molecular mimicry?","volume":"27","author":"Asherson","year":"2000","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2016.09.010_bb0070","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10654-011-9647-5","article-title":"Enigmatic sex disparities in cancer incidence","volume":"27","author":"Edgren","year":"2012","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"10.1016\/j.autrev.2016.09.010_bb0075","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1191\/0961203303lu383ed","article-title":"Autoimmunity and geriatrics: clinical significance of autoimmune manifestations in the elderly","volume":"12","author":"Ramos-Casals","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2016.09.010_bb0080","article-title":"Immunosenescence, aging, and systemic lupus erythematous","volume":"2013","author":"Montoya-Ortiz","year":"2013","journal-title":"Autoimmune Dis"},{"issue":"2","key":"10.1016\/j.autrev.2016.09.010_bb0085","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00005792-199303000-00005","article-title":"Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus","volume":"72","author":"Cervera","year":"1993","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.autrev.2016.09.010_bb0090","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.md.0000091181.93122.55","article-title":"Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients","volume":"82","author":"Cervera","year":"2003","journal-title":"Medicine (Baltimore)"},{"issue":"4 Suppl. 2","key":"10.1016\/j.autrev.2016.09.010_bb0095","first-page":"5","article-title":"Cancer: a disease of the elderly","volume":"1","author":"Ershler","year":"2003","journal-title":"J Support Oncol"},{"issue":"3","key":"10.1016\/j.autrev.2016.09.010_bb0100","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.autrev.2014.11.003","article-title":"Antiphospholipid syndrome and the heart: a case series and literature review","volume":"14","author":"Denas","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2016.09.010_bb0105","first-page":"346","article-title":"The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus","volume":"34","author":"Bayraktar","year":"2007","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2016.09.010_bb0110","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.autrev.2015.01.002","article-title":"The relevance of \u201cnon-criteria\u201d clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features","volume":"14","author":"Abreu","year":"2015","journal-title":"Autoimmun Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216302051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216302051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T07:31:58Z","timestamp":1536391918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997216302051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1568997216302051"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2016.09.010","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2016.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}